Total Payments
$17,860
2024 Payments
$3,739
Companies
39
Transactions
397
Medicare Patients
5,431
Medicare Billing
$473,745
Payment Breakdown by Category
Food & Beverage$10,561 (59.1%)
Other$6,998 (39.2%)
Education$301.43 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,561 | 371 | 59.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,998 | 21 | 39.2% |
| Education | $301.43 | 5 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $7,443 | 44 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,091 | 11 | $0 (2023) |
| PFIZER INC. | $840.78 | 31 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $774.94 | 22 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $771.16 | 20 | $0 (2022) |
| Galderma Laboratories, L.P. | $732.63 | 26 | $0 (2022) |
| Janssen Biotech, Inc. | $700.15 | 29 | $0 (2023) |
| Allergan, Inc. | $698.62 | 18 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $593.29 | 25 | $0 (2023) |
| Celgene Corporation | $472.38 | 18 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,739 | 12 | ABBVIE INC. ($3,710) |
| 2023 | $4,019 | 30 | ABBVIE INC. ($3,334) |
| 2022 | $1,905 | 41 | E.R. Squibb & Sons, L.L.C. ($630.55) |
| 2021 | $1,437 | 54 | Regeneron Healthcare Solutions, Inc. ($253.33) |
| 2020 | $980.83 | 49 | Janssen Biotech, Inc. ($266.66) |
| 2019 | $2,197 | 76 | Sun Pharmaceutical Industries Inc. ($375.35) |
| 2018 | $1,735 | 71 | Celgene Corporation ($308.12) |
| 2017 | $1,848 | 64 | Janssen Scientific Affairs, LLC ($199.72) |
All Payment Transactions
397 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $255.25 | General |
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $37.20 | General |
| 10/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $281.50 | General |
| 08/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $177.00 | General |
| 07/02/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $66.75 | General |
| 06/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $482.90 | General |
| 05/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,045.60 | General |
| 04/11/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $555.15 | General |
| 03/28/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $28.84 | General |
| 03/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $178.50 | General |
| 02/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $398.10 | General |
| 01/05/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $232.20 | General |
| 12/05/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $575.20 | General |
| 11/10/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Immunology | ||||||
| 11/09/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $238.80 | General |
| 10/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Immunology | ||||||
| 10/18/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: DERMATOLOGY | ||||||
| 10/06/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $267.45 | General |
| 09/12/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| 08/08/2023 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Inflammation & Immunology | ||||||
| 08/01/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $329.30 | General |
| 07/29/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: DERMATOLOGY | ||||||
| 07/26/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Immunology | ||||||
| 07/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: IMMUNOLOGY | ||||||
| 07/06/2023 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $155.70 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,407 | 3,604 | $267,534 | $132,250 |
| 2022 | 16 | 1,481 | 3,423 | $283,814 | $133,097 |
| 2021 | 17 | 1,384 | 3,168 | $270,896 | $122,542 |
| 2020 | 16 | 1,159 | 2,504 | $204,515 | $85,855 |
Total Patients
5,431
Total Services
12,699
Medicare Billing
$473,745
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 286 | 428 | $55,829 | $31,577 | 56.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 250 | 418 | $53,626 | $20,988 | 39.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 212 | 1,925 | $25,682 | $12,453 | 48.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 89 | 104 | $23,298 | $10,325 | 44.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 37 | 58 | $18,888 | $9,692 | 51.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 87 | 100 | $15,968 | $8,445 | 52.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 123 | 162 | $13,472 | $7,665 | 56.9% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 13 | 22 | $10,323 | $6,721 | 65.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 129 | 186 | $11,995 | $6,189 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 50 | $9,177 | $4,773 | 52.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $8,994 | $4,228 | 47.0% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 14 | 19 | $6,489 | $2,913 | 44.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 18 | $6,134 | $2,713 | 44.2% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 13 | 16 | $4,690 | $2,176 | 46.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $1,904 | $933.53 | 49.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 12 | $1,045 | $448.77 | 42.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 12 | $19.28 | $10.10 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 260 | 377 | $54,814 | $27,003 | 49.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 278 | 415 | $51,894 | $20,095 | 38.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 224 | 1,731 | $22,873 | $11,280 | 49.3% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 24 | 36 | $16,688 | $11,112 | 66.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 115 | 126 | $27,289 | $11,011 | 40.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 39 | 59 | $18,588 | $9,145 | 49.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 147 | 196 | $17,987 | $8,401 | 46.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 85 | 98 | $17,280 | $8,353 | 48.3% |
About Dr. Thomas Hoffman, M.D
Dr. Thomas Hoffman, M.D is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063435741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Hoffman, M.D has received a total of $17,860 in payments from pharmaceutical and medical device companies, with $3,739 received in 2024. These payments were reported across 397 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($10,561).
As a Medicare-enrolled provider, Hoffman has provided services to 5,431 Medicare beneficiaries, totaling 12,699 services with total Medicare billing of $473,745. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Palo Alto, CA
- Active Since 07/25/2006
- Last Updated 06/19/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1063435741
Products in Payments
- DUPIXENT (Biological) $856.07
- EUCRISA (Drug) $727.89
- Sotyktu (Drug) $630.71
- Otezla (Drug) $548.79
- ILUMYA (Biological) $547.39
- TALTZ (Drug) $466.05
- TREMFYA (Drug) $408.53
- ENSTILAR (Drug) $285.46
- Humira (Biological) $213.70
- EPIDUO FORTE (Drug) $212.40
- DUOBRII (Drug) $202.99
- Ameluz (Drug) $178.84
- Tremfya (Drug) $177.08
- ALTRENO (Drug) $171.32
- JUBLIA (Drug) $166.79
- DUPIXENT DUPILUMAB INJECTION (Biological) $164.57
- AKLIEF (Drug) $149.64
- Enbrel (Biological) $143.07
- Xolair (Biological) $139.23
- SKYRIZI (Biological) $135.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Dermatology $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Dermatology $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Dermatology $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dermatology $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dermatology $19,065
Dr. Miguel Canales, M.d, M.D
Dermatology — Payments: $8,023
Dermatology $8,023